242 related articles for article (PubMed ID: 21354554)
21. Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.
Jayandharan GR; Zhong L; Li B; Kachniarz B; Srivastava A
Gene Ther; 2008 Sep; 15(18):1287-93. PubMed ID: 18496572
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors.
Le Bec C; Douar AM
Gene Ther; 2006 May; 13(10):805-13. PubMed ID: 16453010
[TBL] [Abstract][Full Text] [Related]
23. Light-activated gene transduction of recombinant adeno-associated virus in human mesenchymal stem cells.
Ito H; Goater JJ; Tiyapatanaputi P; Rubery PT; O'Keefe RJ; Schwarz EM
Gene Ther; 2004 Jan; 11(1):34-41. PubMed ID: 14681695
[TBL] [Abstract][Full Text] [Related]
24. Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector.
Koppold B; Sauer G; Büning H; Hallek M; Kreienberg R; Deissler H; Kurzeder C
Int J Oncol; 2005 Jan; 26(1):95-101. PubMed ID: 15586229
[TBL] [Abstract][Full Text] [Related]
25. Adeno-associated virus 2-mediated gene transfer: role of a cellular serine/threonine protein phosphatase in augmenting transduction efficiency.
Zhao W; Wu J; Zhong L; Srivastava A
Gene Ther; 2007 Mar; 14(6):545-50. PubMed ID: 17122803
[TBL] [Abstract][Full Text] [Related]
26. Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy.
Gao Y; Ng SS; Chau DH; Yao H; Yang C; Man K; Huang PT; Huang C; Huang JJ; Kung HF; Lin MC
Cancer Gene Ther; 2008 Nov; 15(11):723-32. PubMed ID: 18535618
[TBL] [Abstract][Full Text] [Related]
27. High throughput production, screening and analysis of adeno-associated viral vectors.
Drittanti L; Rivet C; Manceau P; Danos O; Vega M
Gene Ther; 2000 Jun; 7(11):924-9. PubMed ID: 10849551
[TBL] [Abstract][Full Text] [Related]
28. Adeno-associated virus vectors for gene therapy.
Flotte TR; Carter BJ
Gene Ther; 1995 Aug; 2(6):357-62. PubMed ID: 7584109
[TBL] [Abstract][Full Text] [Related]
29. Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).
Athanasopoulos T; Graham IR; Foster H; Dickson G
Gene Ther; 2004 Oct; 11 Suppl 1():S109-21. PubMed ID: 15454965
[TBL] [Abstract][Full Text] [Related]
30. Enhanced transduction of mouse salivary glands with AAV5-based vectors.
Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA
Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060
[TBL] [Abstract][Full Text] [Related]
31. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors.
Blankinship MJ; Gregorevic P; Chamberlain JS
Mol Ther; 2006 Feb; 13(2):241-9. PubMed ID: 16361117
[TBL] [Abstract][Full Text] [Related]
32. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
33. Recent developments in adeno-associated virus vector technology.
Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
[TBL] [Abstract][Full Text] [Related]
34. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
35. Production and characterization of adeno-associated viral vectors.
Grieger JC; Choi VW; Samulski RJ
Nat Protoc; 2006; 1(3):1412-28. PubMed ID: 17406430
[TBL] [Abstract][Full Text] [Related]
36. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
Grieger JC; Samulski RJ
Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
[TBL] [Abstract][Full Text] [Related]
37. Transduction of human adipose-derived mesenchymal stem cells by recombinant adeno-associated virus vectors.
Locke M; Ussher JE; Mistry R; Taylor JA; Dunbar PR
Tissue Eng Part C Methods; 2011 Sep; 17(9):949-59. PubMed ID: 21563982
[TBL] [Abstract][Full Text] [Related]
38. [Oral recombinant adeno-associated virus gene medicine].
Diao Y; Xu RA
Yao Xue Xue Bao; 2009 Jul; 44(7):703-9. PubMed ID: 19806906
[TBL] [Abstract][Full Text] [Related]
39. Adenovirus and adeno-associated virus vectors.
Lai CM; Lai YK; Rakoczy PE
DNA Cell Biol; 2002 Dec; 21(12):895-913. PubMed ID: 12573049
[TBL] [Abstract][Full Text] [Related]
40. [Novel qPCR strategy for quantification of recombinant adeno-associated virus serotype 2 vector genome-titer].
Meng Q; Zhang B; Zhang C
Sheng Wu Gong Cheng Xue Bao; 2013 Feb; 29(2):235-42. PubMed ID: 23697168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
